Male breast cancer (MBC) is an uncommon neoplasm that shares several biologic
characteristics with its female counterpart. In the latter, abnormalities in the expression …

Introduction One of the most common genetic aberrations associated with breast cancer is
the amplification and overexpression of the ERBB2 proto-oncogene located at chromosome …

Background: Recently, HER2-negative breast cancers have been reclassified by protein
expression into 'HER2-low'and 'HER2-zero'subgroups, but the consideration of HER2-low …

PURPOSE: To investigate the prognostic value of biomarkers in male breast carcinoma
(MBC). PATIENTS AND METHODS: Fifty patients (mean age, 62.2 years) with invasive …

Male breast cancer is rare, and experience of it in any single institution is limited. Our current
understanding regarding its biology, natural history, and treatment strategies has been …

Male breast cancer (MBC) is a rare disease. To date, therapy is mainly based on studies and
clinical experiences with breast cancer in women. Only little is known about molecular typing …

The prognostic role of ploidy status, S phase fraction, estrogen and progesterone receptor
status, and the expression of p 53 and erbB-2 protein in male breast carcinoma (MBC) …

Backgrounds Male breast cancer (MBC) is a rare disease and accounts for< 1% of all breast
cancers. Methods We retrospectively analyzed clinicopathologic characteristics and …

Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …

We analyzed DNA from 105 primary breast cancers to assess amplification of the ERBB2
gene and loss of heterozygosity (LOH) on chromosome 17 using 4 polymorphic markers …